Niagen Bioscience
NAGE
#9266
Rank
A$0.21 B
Marketcap
A$2.76
Share price
-1.60%
Change (1 day)
-74.16%
Change (1 year)

Earnings for Niagen Bioscience (NAGE)

Earnings in 2026 (TTM): A$16.19 Million

According to Niagen Bioscience's latest financial reports the company's current earnings are A$0.12 Billion. In 2025 the company made an earning of A$27.33 Million, an increase over its 2024 earnings that were of A$13.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Niagen Bioscience from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$16.19 M-40.75%
2025 A$27.33 M105.44%
2024 A$13.3 M-279.32%
2023 -A$7.42 Million-70.15%
2022 -A$24.85 Million-39.03%
2021 -A$40.76 Million36.15%
2020 -A$29.94 Million-38.02%
2019 -A$48.3 Million-3.51%
2018 -A$50.06 Million101.55%
2017 -A$24.84 Million470.57%
2016 -A$4.36 Million4.72%
2015 -A$4.16 Million-48.66%
2014 -A$8.1 Million21.92%
2013 -A$6.64 Million-62.08%
2012 -A$17.51 Million48.18%
2011 -A$11.82 Million289.87%
2010 -A$3.04 Million125.95%
2009 -A$1.35 Million-54.35%
2008 -A$2.94 Million8290.97%
2007 -A$0.04 Million